27
Aug
2024

Fujian South Pharmaceutical Co., Ltd.

Exhibitor at CPHI Korea 2024 stand F26
About Us

Fujian South Pharmaceutical Co Ltd (FSP) was established in 2001, located in Mingxi County, Fujian Province, China. Today, FSP has become an important cGMP manufacturer for oncology APIs in China. FSP cultivates 7,000 acres of Taxus Wallichiana (Taxus yunnanensis), and it is the largest commercial utilizing in China. FSP is the main supplier for natural Paclitaxel, semi-synthesis Paclitaxel, Docetaxel, 10-DAB III (Taxus Baccata and Taxus Wallichiana) in the world. FSP is a main supplier for Gemcitabine, Irinotecan and the patented technologies for Docetaxel, Imatinib, and Erloitnib, etc.

...

  • CN
  • 2015
    On CPHI since
Company types
Manufacturer/Innovator
Contact info
Event information
CPHI Korea 2024
  • 27 Aug 2024 - 29 Aug 2024
  • COEX, Seoul, Korea
  • Visit us at stand F26

Products Featured at CPHI Korea 2024

  • 5-aminolevulinic acid HCl

    Product 5-aminolevulinic acid HCl

    5-ALA HCl: 5-Aminolevulinic acid hydrochloride; 5-ALA methyl ester: 5-Aminolevulinic acid methyl ester hydrochloride.